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Abstract
Release factors (RFs) govern the termination phase of protein synthesis. Human mitochondria harbor four different
members of the class 1 RF family: RF1Lmt/mtRF1a, RF1mt, C12orf65 and ICT1. The homolog of the essential ICT1 factor is
widely distributed in bacteria and organelles and has the peculiar feature in human mitochondria to be part of the ribosome
as a ribosomal protein of the large subunit. The factor has been suggested to rescue stalled ribosomes in a codon-
independent manner. The mechanism of action of this factor was obscure and is addressed here. Using a homologous
mitochondria system of purified components, we demonstrate that the integrated ICT1 has no rescue activity. Rather,
purified ICT1 binds stoichiometrically to mitochondrial ribosomes in addition to the integrated copy and functions as a
general rescue factor, i.e. it releases the polypeptide from the peptidyl tRNA from ribosomes stalled at the end or in the
middle of an mRNA or even from non-programmed ribosomes. The data suggest that the unusual termination at a sense
codon (AGA/G) of the oxidative-phosphorylation enzymes CO1 and ND6 is also performed by ICT1 challenging a previous
model, according to which RF1Lmt/mtRF1a is responsible for the translation termination at non-standard stop codons. We
also demonstrate by mutational analyses that the unique insertion sequence present in the N-terminal domain of ICT1 is
essential for peptide release rather than for ribosome binding. The function of RF1mt, another member of the class1 RFs in
mammalian mitochondria, was also examined and is discussed.
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Introduction
Stalled ribosomes must be rescued for productive cycles of
cellular protein synthesis. So far, three rescue systems for
ribosomes stalled at the ends of nonstop mRNAs have been
identified in bacteria. The most thoroughly characterized pathway
is the trans-translation system involving tmRNA [1].
The second pathway engages ArfA (formerly YhdL) [2,3], a
small protein composed of approximately 55 residues. ArfA was
originally identified as a factor essential for the viability of E. coli
in the absence of tmRNA, and accordingly was renamed ArfA, for
alternative ribosome-rescue factor. ArfA, in concert with RF2,
takes over the rescue of stalled ribosomes, where RF2 hydrolyzes
peptidyl-tRNA in a GGQ motif-dependent but codon-indepen-
dent manner.
The third pathway is mediated by ArfB (formerly YaeJ) [4].
This factor is a reduced paralogue of the bacterial class 1 release
factors (RFs) that retains domain 3 but lacks domains 1, 2 and 4.
Domains 2 and 4 are essential for stop-codon recognition, whereas
domain 3 contains the GGQ-motif. In agreement with this, the
ArfB in E. coli hydrolyzes the peptidyl-tRNAs of ribosomes stalled
at the 39-ends of nonstop mRNAs, and functions codon-
independently. The deletion of the genes of both tmRNA and
ArfB is not lethal in contrast to that of tmRNA and ArfA, but the
overexpression of ArfB alone rescues the double depletion of
tmRNA and ArfA. Accordingly, it was suggested that this factor
should be renamed ArfB, for alternative ribosome rescue factor B.
The crystal structure of ArfB, bound to the Thermus thermophilus
70S ribosome in complex with the initiator tRNAi
fMet and a short
mRNA, has been determined [5]. The N-terminal globular
domain of ArfB occupies the A site of the 50S subunit next to
the P-site tRNA, and its C-terminal tail occludes the mRNA
tunnel downstream of the 30S A-site. The latter is thought to
function as a sensor to detect a stalled ribosome, based on the
occupancy of the mRNA entry channel. Indeed, ArfB prefers a
ribosomal complex with a nonstop mRNA, where the A-site is
vacant on the ribosome [3]. Subsequently, the binding of the tail
within the mRNA entry channel allows the N-terminal globular
domain to optimally position its GGQ motif in the peptidyl-
transferase center (PTC) and to catalyze the hydrolysis of peptidyl-
tRNA. Unlike the other class 1 RFs, ArfB contains a 25 residue
insertion sequence in its N-terminal globular domain. The
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function of this sequence in a codon-independent peptide release
factor is unknown.
We have only scarce knowledge about the ribosome rescue
system in mitochondria. The so-called ‘‘immature colon carcino-
ma transcript-1’’ (ICT1) is a bacterial ArfB homolog in
mammalian mitochondria; members of this factor family are
widely distributed in bacteria and organelles of all eukaryotic phyla
[6]. No homologs for either tmRNA or ArfA have been found in
mammalian mitochondria. ICT1 catalyzes the release of for-
mylmethionine from its P-site fMet-tRNA in E. coli 70S
ribosomes, in a codon-independent manner [7]. ICT1 is an
essential mitochondrial protein, and a mutation in the GGQ-motif
of ICT1 causes loss of cell viability [7]. These observations
suggested that ICT1 may be responsible for the ribosome rescue in
mammalian mitochondria. Strangely, ICT1 is an integral compo-
nent of the mitochondrial ribosome (mitoribosome [7,8]). ICT1 is
a member of the large mitoribosomal subunit (mitochondrial
ribosomal protein L58, MRPL58), and a crucial component for its
assembly [7]. No other RF family protein has been shown to be an
integral ribosomal component. It is unclear, how the integrated
ICT1 functions to rescue stalled ribosomes in the mammalian
mitochondrial translation system.
In the present study, we have investigated the function of
human mitochondrial ICT1, utilizing 55S mitoribosomes purified
from pig liver mitochondria. We demonstrate that the codon-
independent peptide-release activity on 55S ribosomes is only
observed, when we add ICT1 to the system containing the 55S-
integrated ICT1 (or to a system containing bacterial 70S
ribosomes lacking integrated ICT1). These results suggest that
the 55S-integrated ICT1 lacks peptide-release activity, as
opposed to a previous model [7]. We further show that ICT1
can rescue ribosomal complexes not only at the ends of mRNAs,
but also in the middle of mRNAs, and even without mRNAs.
Our data suggest that ICT1 is a versatile ribosome rescue factor,
which is also involved in the translation termination at non-
standard stop codons AGG and AGA in mammalian mitochon-
dria. The unique insertion sequence in the N-terminal domain of
ICT1 is required for peptide release rather than involved in
binding to the ribosome as demonstrated by a mutational
analysis.
Results
ICT1 shows codon-independent peptide-release activity
on 55S mitoribosomes, independent of the 55S-
integrated ICT1
ICT1 is a component of the 55S mitochondrial ribosome
(mitochondrial ribosomal protein L58, MRPL58) [7,8]. However,
it was not clear whether the 55S ribosome itself with the integrated
ICT1 exhibits the basal peptide-release activity, or whether an
exogenous ICT1 can function on the 55S ribosome. To address
these questions, we prepared 55S mitoribosomes from pig liver
mitochondria as a model for human mitochondria, and tested
them in a peptide-release assay. Pig mitochondrial ribosomes share
high homology with those from human mitochondria and are
easier to prepare. As shown in Fig. 1A (upper panel), 55S
ribosomes contained a full complement of ICT1 in a 1:1
stoichiometry (Fig. 1A, upper panel), which was a component of
the large 39S mitoribosomal subunit (Fig. 1A, lower panel),
consistent with the previous reports [7,8].
In the peptide-release assay, a ribosomal complex was
constructed using the 55S mitoribosome, mRNA encoding either
MF-stop (UAA) or MFV, and N-acetyl-[3H]Phe-tRNAPhe
(ac[3H]Phe-tRNAPhe) as a model of peptidyl-tRNA. Accordingly,
ac[3H]Phe-tRNAPhe was present at the P-site, and the stop codon
(UAA) or sense codon for Val (GUU) was at the A-site in the
complex. The released ac[3H]Phe from tRNA was assessed in the
presence of peptide release factors; values in the absence of release
factors were taken as background and subtracted from the
measured values (Fig. 1B). The mitochondrial termination factor
RF1Lmt/mtRF1a showed efficient peptide-release activity with
MF-stop(UAA) mRNA, but not with MFV mRNA, as expected
(Fig. 1B, RF1Lmt) [9,10]. Approximately 90% of the ac[3H]Phe-
tRNAPhe on the ribosome programmed by MF-stop(UAA) mRNA
was hydrolyzed by RF1Lmt/mtRF1a. RF1mt, a class 1 RF family
protein in mammalian mitochondria with an unknown function,
did not show peptide-release activity for both mRNAs (Fig. 1B,
RF1mt), even using an excess amount (Fig. S1). All the results with
RF1mt hereafter are discussed later.
ICT1 showed the ac[3H]Phe release activity for both MF-
stop(UAA) mRNA and MFV mRNA on 55S ribosomes (Fig. 1B,
ICT1), consistent with its codon-independent peptide-release
activity on 70S ribosomes [7]. Unexpectedly, the activity of
ICT1 greatly exceeded the 100% value. We suspected that ICT1
performs multiple reaction cycles on the ribosome until the acPhe-
tRNA input has been consumed, but perhaps with that fraction of
ribosomes, which does not carry mRNA. Therefore, we performed
peptide-release assays in the absence of mRNA; Fig. 1C exhibits
ICT1 peptide-release activity under this condition, but only in the
presence of 55S ribosomes (compare 55S[+] and 55S[2]), and
even Phe is quantitatively released from Phe-tRNA when bound to
non-programmed 55S ribosomes (Fig. S2A). Accordingly, most of
the ICT1 activity observed in the presence of mRNA actually
originated from multiple reactions on mRNA-free ribosomal
complexes; ICT1 releases AcPhe in the absence of mRNA also
with bacterial 70S ribosomes as does ArfB (Fig. S3). Both RF1Lmt
and RF1mt are not able to release peptides from peptidyl-tRNA
bound to non-programmed mitoribosomes (Fig. 1C, RF1Lmt and
RF1mt). The 55S ribosomes alone (containing stoichiometric
amounts of ICT1) did not show peptide-release activity in the
peptide release experiments (for example, see Fig. 1C, compare
RF[2] of 55S[+] and 55S[2]). These results indicated that the
ICT1 integrated in the ribosome does not exhibit the peptide-
release activity.
Author Summary
Mammalian mitochondrial ICT1, a bacterial ArfB homolog,
is interestingly an integral component of the mitoribo-
some (MRPL58). The mechanism of ribosome rescue by
this factor was obscure and is addressed here. Utilizing a
homologous mitochondria system of purified components
we demonstrate that the integrated ICT1 has no rescue
activity, as opposed to a previous model. Rather, purified
ICT1 added to mitoribosomes has a general rescue activity;
it recycles ribosomes stalled at the end or in the middle of
mRNAs and can even hydrolyze peptidyl-tRNA bound to
non-programmed ribosomes. These results further imply
that ICT1 can function in the translation termination at
non-standard stop codons AGA/G in mammalian mito-
chondria. Our data challenge a previous model claiming
that RF1Lmt/mtRF1a is responsible for the translation
termination at non-standard stop codons. A mutational
study indicates that the unique insertion sequence in ICT1
is essential for peptide release. The function of RF1mt,
another member of the class1 RFs in mammalian mito-
chondria, was also examined and is discussed.
ICT1 Is a Versatile Mitoribosome Rescue Factor
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Figure 1. ICT1 shows codon-independent peptide-release activity on 55S mitoribosomes. (A) ICT1 is integrated within the 39S large
mitoribosomal subunit in a 1:1 stoichiometry. The amounts of 55S-integrated ICT1 on 55S ribosomes were estimated by Western blotting, using the
purified ICT1 protein as a standard (Std. ICT1; upper panel). 55S mitoribosomes (lower left panel) or mitoribosomal subunits (lower right panel) were
ICT1 Is a Versatile Mitoribosome Rescue Factor
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We have shown in this section that ICT1 shows codon-
independent peptide release activity when added to 55S mitoribo-
somes; the activity is not caused by the 55S-integrated ICT1.
Added ICT1 is able to exhibit peptide release activity even in the
absence of mRNA. These results suggest that the 55S-integrated
ICT1 is not present at the active site, where a release factor has to
bind in order to trigger the release of the peptide.
ICT1 can rescue stalled ribosomes in the middle of mRNA
In the next experiment we performed a multi-round translation
assay. We utilized an Escherichia coli-based reconstituted in vitro
system of coupled transcription-translation [11], which has the
advantage that the 70S ribosomes do not contain integrated ICT1
(ArfB) factors. The peptide release factors were omitted from the
system, in order to allow a specific analysis of the effects of ICT1
or other release factors. The ribosomes were programmed with
mRNAs encoding a short polypeptide (MFFLF). We applied three
different mRNAs: a nonstop mRNA without a 39-end, and the
stop (UAA) and stall (AGA) mRNAs, both of which have a 39-
UTR with 14 nucleotides (Fig. 2A, upper sketch in the upper
panel, and Materials and Methods). The translation efficiencies
were assessed by the incorporation of f[14C]Met. The ribosome
recycling factor cannot hydrolyze a peptidyl-tRNA bound to
ribosomes. Accordingly, the yield of the isolated polypeptides
reflects the peptide-release activity of ICT1 with ribosomes stalled
at the 39 end of the mRNA or in the middle of the mRNA. ICT1
does not interfere with normal translation, because even excess of
ICT1 in addition of the mito-release factor RF1Lmt does not
affect the kinetics of the peptide release during the termination
phase after the synthesis of the pentapeptide (Fig. S2B).
Interestingly, ICT1 could release the oligo-peptide from stalled
ribosomes programmed with the stop(UAA) or the stall(AGA)
mRNAs, although to a lesser extent than with the nonstop(2)
mRNA (Fig. 2A, lower panels). ICT1 functioned with the
stop(UAA) and stall(AGA) mRNAs almost as efficiently as
RF1Lmt did with the stop(UAA). After 30 minutes of synthesis,
ICT1 yielded a release of ,0.3 pmol polypeptides with the
stop(UAA) and stall(AGA) mRNAs, and of ,2.0 pmol with the
nonstop(2) mRNA. RF1Lmt released ,0.5 pmol polypeptides
with the stop(UAA). These results suggest that ICT1 can rescue a
stalled ribosome in the middle of the mRNA.
Next, we analysed, whether ICT1 can also release polypeptides
from native polysomes, in which most of the ribosomes are in the
middle of the mRNA. The control is a treatment with the
antibiotic puromycin, which is an analogue of the 39-end of an
aminoacyl-tRNA, binds to the A-site region of the PTC, receives
the polypeptide from the peptidyl-tRNA in the P site via a peptide-
bond and leaves the ribosome as peptidyl-puromycin [12]. The
action of puromycin on polysomes is indicated by a polysome-
breakdown and an increase of the ribosomal subunits, (Fig. 2B,
compare first two panels). The next three panels demonstrate that
ICT1 is as effective as puromycin in breaking down the polysomes
in contrast to RF1Lmt and RF1mt. ICT1 showed significant
puromycin-like peptide-release activity on the polysomes, even
though the A-sites on the polysomes are occupied with mRNA (the
rightmost panel). RF1Lmt did not exhibit this activity, since
polysomes do not carry a stop codon in their A-site (the third panel
from the left).
Collectively, our results demonstrated that ICT1 can rescue
stalled ribosomes in the middle of mRNA occupying the mRNA
tunnel. These observations support the recent structural model of
ICT1, according to which the C-terminal tail of ICT1 does not
enter the mRNA path downstream of A-site of the ribosomal small
subunit, at least as long as the ribosome stalling occurs in the
middle of an mRNA [13]. Our findings also suggest that ICT1 is
involved in the translation termination at non-standard stop
codons AGA and AGG in mammalian mitochondria.
In all assays of both the multi-round translation and the
polysome breakdown, RF1mt did not show peptide-release activity
with any mRNA construct examined (Fig. 2A and B, RF1mt),
consistent with the results of the peptide-release assay (Figs. 1B
and C, RF1mt).
The peptide-release activity of ICT1 requires the insertion
sequence in the N-terminal globular domain
The classical class 1 RF proteins need to recognize the stop
codon and simultaneously to place their GGQ-motif in the
peptidyl-transferase center (PTC) of the ribosome. Bacterial RF1/
RF2 has the ‘‘switch loop’’ between domains 3 and 4 (Figs. 3A and
B) [14,15]. Stop codon recognition by domains 2 and 4 induces
the rearrangement of this loop structure, thus positioning the
GGQ-motif of domain 3 in the PTC (Fig. 3B, see the sketch of
RF2 on the ribosome). On the other hand, the codon-independent
peptide release factors, such as ArfB and ICT1, possess only
domain 3 and lack the switch loop: domain 3 is connected by the
flexible linker to its C-terminal tail that is thought to occupy the
mRNA channel of the ribosome [5]. It is not clear how the GGQ-
motif of ICT1 is optimally positioned in the PTC. In this regard, it
is interesting that both ArfB and ICT1 uniquely contain an
insertion sequence of 25 residues in the globular domain 3, in
contrast to the classical class 1 RFs (Fig. 3B and C) [5,7].
Therefore, we examined the function of the insertion sequence.
We first applied the peptide-release assay with 55S ribosomes in
the absence of mRNA. There are five basic amino acid residues in
the insertion sequence: R116, K118, K124, K126 and R129
(Fig. 3C, highlighted with red letters; and Fig. 3D). Assuming that
the basic amino acid residues are involved in the interaction with
ribosomal RNA, alanine substitutions were introduced at these
positions. The peptide-release analyses revealed that the ICT1[a2]
mutant, in which K124, K126 and R129 are simultaneously
mutated to alanine, had little activity (Fig. 4A, ICT1[a2]). The
activity of ICT1[a2] was almost as low as those of the ICT1[GSQ]
and ICT1[DC] mutants, in which the GGQ-motif was changed to
GSQ and the C-terminal 14 amino acids were truncated,
respectively (Fig. 4A, ICT1[GSQ] and ICT1[DC]). The GGQ
motif is critical for the peptide-release activity of ICT1 on the 70S
separated on 15%–30% (w/v) sucrose gradients (containing 10 mM Tris-HCl [pH 7.4], 80 mM NH4Cl, 8.2 mM MgSO4, and 1 mM DTT, for 55S; 10 mM
Tris-HCl [pH 7.4], 200 mM KCl, 2 mM MgCl2, 2 mM GDP and 1 mM DTT, for subunits), and the fractions were analyzed by Western blotting with an
ICT1 antibody. IB, immunoblotting. (B) Exogenous ICT1 exhibits codon-independent peptide-release activity on 55S mitoribosomes. The ac[3H]Phe
release activities of ICT1, RF1Lmt and RF1mt on 55S ribosomes were tested in the presence of mRNAs and ac[3H]Phe-tRNAPhe. Ribosomes were
programed by mRNAs encoding MF-UAA (stop) or MFV (sense). The results were evaluated relative to the 100% value, when all of the ac[3H]Phe-
tRNAPhe bound to ribosome was hydrolyzed; 100% value corresponds to 0.9 pmol of ac[3H]Phe. Results represent the average of at least three
independent experiments. The error bars indicate standard deviation (SD). (C) ICT1 shows peptide release activity on 55S mitoribosomes in the
absence of mRNA. Peptide-release assays on 55S ribosomes were performed as in (B), but in the absence of mRNA. 55S [+] and 55S [2] indicates the
assays in the presence and absence of 55S mitoribosomes, respectively. Results represent the average of at least three independent experiments. The
bars on the graph indicate SD.
doi:10.1371/journal.pgen.1004616.g001
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Figure 2. ICT1 can function in the middle of the mRNA. (A) ICT1 significantly functions with stop (UAA) and stall (AGA) mRNAs. Multi-round
translation assays with E. coli 70S ribosomes were performed with the indicated peptide release factors, using mRNAs depicted in the upper. Each
mRNAs differs at the 39-terminus. Nonstop, no stop codon and no 39UTR; stop, UAA stop codon followed by 39UTR; sense, AGA sense codon followed
by 39UTR. The ribosomes stall at the AGA codon, since only phenylalanyl-tRNA synthetase and leucyl-tRNA synthetase are present as aminoacyl-tRNA
synthetase sources. The amounts of synthesized peptide were evaluated with nonstop (upper right), stop (lower left), and stall (lower right). Also note
that ICT1 functions more efficiently when the A-site is vacant (compare ICT1[WT] among nonstop, stop and sense). The results represent the average
of at least three independent experiments. The bars on the graph indicate SD. For details, see the text. (B) ICT1 exhibits peptide-release activity on
ICT1 Is a Versatile Mitoribosome Rescue Factor
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ribosome [7]. The C-terminal 10 amino acids of ArfB, which
correspond to the C-terminal 14 amino acids of ICT1, are
essential for its ribosome binding capacity [4].
We also performed the multi-round translation assay to assess
the peptide release activities of the ICT1 mutants. The ribosomes
were programmed by a nonstop mRNA encoding a short
polypeptide (MFFLF) without a stop codon (Fig. 4B, left). When
wild type ICT1 was included in the system, the translation
efficiency was increased, reflecting the enhanced multi-round
translation (Fig. 4B, right, red closed squares). An alanine
substitution of any one of the basic resides in the insertion
sequence showed various defects (Fig. S4). However, when
ICT1[a2] was included in the system, peptide release was
abolished (Fig. 4B; green open squares). Neither ICT1[GSQ]
nor ICT1[DC] enhanced the release (Fig. 4B; red open squares
and green closed squares). These results suggest that the peptide-
release activity of ICT1 is dependent on the insertion sequence in
the N-terminal globular domain.
The insertion sequence in the N-terminal globular
domain of ICT1 is not involved in ribosome binding
The mutations in the insertion sequence of ICT1 led to a loss of
peptide-release activity (Fig. 4). Whether or not this loss was
caused by a loss of binding to the ribosome was tested in the next
experiment. Excess amounts of ICT1 proteins were incubated with
55S mitoribosomes or 70S E. coli ribosomes. The mixtures were
then fractionated on a sucrose density gradient, and the ICT1
proteins were detected by immunoblotting of the fractions
(Fig. 5A). For the analysis with 55S mitoribosomes, N-terminal
his-tagged ICT1 proteins were used to discriminate the exogenous
ICT1 from the endogenous ICT1; the exogenous his-tagged ICT1
could be separated from the endogenous ICT1 in SDS-PAGE,
according to the increased molecular weight due to the his-tag.
Both ICT1 and ICT1[a2] bound similarly to the 55S mitoribo-
somes (Fig. 5A, upper panels) and 70S ribosomes (Fig. 5A, lower
panels). It is of note here that ICT1 proteins were incubated with
55S or 70S ribosomes in a 17-fold or 10-fold excess relative to the
ribosomes, and approximately 5% and 10% of the input ICT1 was
bound to the 55S and 70S ribosomes, respectively. This means
that both 55S and 70S bound exogenous ICT1 with nearly a 1:1
stoichiometry. These results clearly indicate that 55S ribosomes,
already bearing the integrated ICT1, possess two ICT1 binding
sites.
In Fig. 5B, the ribosome binding of wild type ICT1 or
ICT1[a2] was analyzed more quantitatively. The 70S ribosomes
were incubated with various amounts of ICT1 proteins, in up to 4-
fold excess relative to 70S ribosomes. The ribosome-bound ICT1
proteins were then recovered by a filtering technique, and
quantified by Western blotting against ICT1. The amounts of
ribosome-bound ICT1 per 70S ribosome were plotted against the
input-amounts of ICT1. The results confirmed that ICT1 and
ICT1[a2] exhibit similar ribosome binding abilities.
The ribosome binding of wild type ICT1 or ICT1[a2] was
further analyzed with 55S mitoribosomes in the presence of the
crosslinking agent BS3, as shown in Fig. 5C. In this experiment,
we aimed to obtain information about the binding site of
exogenous ICT1 as well as that of the integrated ICT1 on the
55S ribosome. The 55S ribosomes were incubated with either wild
type ICT1 or ICT1[a2] in the presence of BS3. The cross-linked
products were fractionated by SDS-PAGE, and analyzed by
Western blotting with an ICT1 antibody. Similar cross-linking
products of wild type ICT1 and ICT1[a2] were observed (two
asterisks), which was different when no ICT1 was added (one
asterisk). These observations indicate that the binding sites of the
55S-integrated ICT1 and that of the exogenous ICT1 on the 55S
ribosome are different.
Taken together, the results suggested that the insertion sequence
of ICT1 does not affect the ribosome binding, which depends on
the C-terminal tail of ICT1. We propose that the interaction of the
insertion sequence with the ribosome is responsible for an optimal
positioning of the GGQ-motif of ICT1 in the peptidyl-transferase
center.
Discussion
A previous study addressing the function of ICT1 used a
heterologous combination of E. coli 70S ribosomes and human
mitochondrial ICT1 [7]. In the present study, we employed
homologous systems in most experiments: 55S mitochondrial
ribosomes and purified mitochondrial factors including human
mitochondrial ICT1. Our analyses revealed that exogenous ICT1
functions independently of the 55S-integrated ICT1; the 55S-
integrated ICT1 shows no peptide-release activity. This is in
agreement with a recent cryo-EM analysis at 4.9 A˚ resolution of
the large subunit of porcine mitochondrial ribosomes, according to
which ICT1 is located at the base of the central protuberance .
70 A˚ away from the A site [16]. A conformational change of the
large ribosomal subunit bringing the integrated ICT1 to the A-site
is hardly conceivable.
So far, ribosome-free ICT1 has not been yet detected in
mitochondria [7]. Thus, a possible explanation for our observation
is that the ribosome-integrated ICT1 may be released from
ribosomes, which are stalled under certain cellular conditions; the
liberated ICT1 then binds to the ribosomal A-site to exert its
peptide-release activity (Fig. 6). In mammalian mitochondria, all
of the mtDNA-encoded proteins are membrane proteins, which
are probably co-translationally inserted into the mitochondrial
inner membrane [17]. Therefore, the substrates of ICT1 could be
ribosomes that become stalled during the insertion of the nascent
peptide into the membrane. Defects in polypeptide insertion into
the membrane would cause the nascent polypeptide to become
stuffed in the tunnel, and eventually stall the ribosome. It is
possible that the stuffed nascent polypeptide in the tunnel of the
stalled ribosome causes a structural change in the large ribosomal
subunit, which might be important for recognition of ICT1 and
might even elicit the release of ICT1 from the ribosome. Further
studies, such as search for the ribosome-free ICT1, are required to
support this hypothesis. It is also possible that ICT1 is
overexpressed in response to a ribosome stalling in order to
produce ribosome-free ICT1, which acts on the stalled ribosome
independently of the integrated ICT1.
Our analyses revealed that ICT1 functions as a versatile rescue
factor, i.e. it releases the polypeptide from the peptidyl-tRNA from
ribosomes stalled at the end or in the middle of an mRNA or even
from non-programmed ribosomes (Fig. 6). The ability of ICT1 to
hydrolyze the peptidyl-tRNA on the non-programmed ribosome,
i.e. in the absence of mRNA, may have some advantages in
mitochondrial translation. For example, ICT1 may rescue a
the polysome similar to that of puromycin. The polysome breakdown assay was performed as described previously [25]. E. coli polysomes (2.0 A260)
were incubated with ribosome recycling factors (RRFmt, 15 mg; EF-G2mt, 30 mg) in the presence of the indicated peptide release factors (RF1Lmt or
RF1mt, 60 mg; ICT1, 50 mg; puromycin, 10 mM), and subjected to sucrose gradient centrifugation.
doi:10.1371/journal.pgen.1004616.g002
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defective initiation complex, e.g. a ribosomal complex that binds
fMet-tRNA in the absence of mRNA.
The ability of ICT1 to hydrolyze the peptidyl-tRNA on the
ribosome in the middle of an mRNA would imply that ICT1
functions as a termination factor as well as a rescue factor. This
assumption is supported by observations in S. pombe, according to
which the growth defects observed in a Mrf1 (mitochondrial
release factor)-deficient strain are compensated by overproduction
of Pth4, which is a counterpart of human ICT1 and is also a
component of the large subunit of the mitoribosome [18]. In
human, mtDNA-encoded cytochrome c oxidase subunit I (CO1)
and NADH dehydrogenase 6 (ND6) carry AGA and AGG codons
at the end of their mRNAs, respectively. There are no tRNAs in
mammalian mitochondria that decode AGA/G codons, viz.
AGA/G codons are unassigned codons in mammalian mitochon-
dria. Ribosomes stalled at these codons might be recognized by
ICT1, i.e. it would function as a specific translation termination
factor for CO1 and ND6 in human mitochondria. It has been
shown that AGA/G codons in CO1 and ND6, presumably in
association with other cis elements, promote 21 frameshifting in
human mitoribosomes providing an UAG stop codon at the
ribosomal A-site for both CO1 and ND6 mRNA. Accordingly, it
was proposed that the translation of CO1 and ND6 are terminated
by RF1Lmt [19]. However, a U preceding AGA/G is rare in
mitochondria of most vertebrates [13]. Moreover, the peptidyl-
tRNA at the P-site can no longer interact with the mRNA via
codon-anticodon interactions after the frameshift, and thus the
peptidyl-tRNA would probably not be able to keep the P/P state,
which is a requirement for the peptide release by RF1Lmt.
Therefore, it is still unclear whether RF1Lmt or ICT1 catalyze the
peptide release of CO1 and ND6.
The mutations of basic residues in the insertion sequence of
ICT1 caused a loss of peptide release activity, but did not affect its
ribosome binding ability (Figs. 4 and 5, respectively). The crystal
structure of ArfB/YaeJ on the 70S ribosome revealed that the
insertion sequence in the N-terminal globular domain interacts
with 23S rRNA [5]. The phosphate backbones of U1946 and
C1947 in 23S rRNA form hydrogen-bonds with the main chain N
atom of His62 and the Oc atom of Ser60 of ArfB, respectively (Fig.
S5). Although these residues are not conserved in ICT1, it is
plausible that other residues in the insertion region interact with
rRNA in the large mitochondrial ribosomal subunit. The
mutations of basic residues in the insertion region of ICT1 might
disrupt the proper interaction between the insertion sequence and
rRNA, without affecting the ribosome binding ability of ICT1,
which is governed by the C-terminal tail of ICT1. The role of the
insertion sequence of ICT1 or ArfB, the codon-independent
peptide release factors, could be to place the GGQ-motif in the
appropriate orientation for peptide release. Very recently, effects
of the point mutations in the insertion sequence of ArfB have been
studied [20]. Decreased peptide release activities were observed for
some mutants, probably due to the inappropriate orientation of
the GGQ-motif. In bacteria, ArfA assists RF2 for the codon-
independent peptide-release activity [2,3]. Although a structural
study is required to verify how ArfA functions with RF2, it is
possible that ArfA plays the same role as the insertion sequence of
ICT1/ArfB.
ICT1 is one of four proteins of the class 1 RF-family in
mammalian mitochondria: RF1Lmt/mtRF1a, RF1mt, C12orf65
and ICT1 [21]. Despite great efforts, the roles of RF1mt and
C12orf65 are not known. A previous structural simulation study
proposed that the RF1mt targets the ribosomal complex with a
vacant A-site, and thus is a candidate for the ribosome rescue
factor in mammalian mitochondria [21]. Another simulation study
proposed that the RF1mt would display peptide release activity for
UAA and UAG stop codons, but exclusively on 55S mitoribosome
[13]. However, using such ribosomal complexes, we could not
detect any peptide release activity of RF1mt by itself (Figs. 1B, 1C
and 3B). It is possible that RF1mt shows peptide release activity
through its GGQ motif in collaboration with unknown factors, as
bacterial RF2 shows codon-independent peptide release activity in
concert with ArfA [2,3].
In spite of some answers concerning translation termination in
mitochondria given in this study, still important questions remain,
e.g. under which conditions ribosome-free ICT1 is produced to act
on the ribosomal A-site.
Materials and Methods
Preparation of 55S ribosomes
55S ribosomes were prepared from pig liver mitochondria, as
described previously [22]. The ribosome concentrations were
calculated assuming 32 pmol/A260 for 55S ribosomes.
Expression and purification of Human ICT1
HMICT1/pET15b was used as the E. coli expression vector for
the N-terminally histidine-tagged ICT1. The EST clone
(IOH11951) was purchased from Invitrogen. The coding sequence
was amplified by PCR, using the primers 59-CGGTG-
CCCACGCCATATGCTGCACAAGCAGAAAGACGGCAC-
TG-39 and 59-GAGGCTCGAGTCAGTCCATGTCGACCCT-
CCTGCTT-39. The obtained coding sequences were cloned
between the NdeI and XhoI sites of a modified pET15b vector
(Novagen), in which the original multi-cloning sites were modified
in our laboratory.
HMICT1/pET15b was transformed into E. coli Rosetta(DE3)/
pLysS. Cultures were induced with 100 mM isopropyl-1-thio-D-
galactopyranoside at 18uC overnight. The protein was purified by
Ni-NTA (QIAGEN) column chromatography. After histidine tag
digestion using thrombin protease (GE Healthcare), the protein
Figure 3. Structural comparison of ICT1 with the classical class 1 release factors. (A) Comparison of the domain-structures of Thermus
thermophilus RF2, E. coli ArfB/YaeJ, and mouse ICT1. For Thermus thermophilus RF2, the catalytic domain 3 is indicated in blue, the stop codon
recognition domain (consisting of domains 2 and 4) is shown in orange, and domain 1 is colored red. The switch loop is highlighted in green. For
ArfB/YaeJ and ICT1, the N-terminal globular domain is shown in blue. (B) Comparison of 3D-structures of Thermus thermophilus RF2 [14] (PDB code
2WH1), E. coli ArfB/YaeJ [5] (PDB code 4DH9), and mouse ICT1 [26] (PDB code 1J26). Each domain of RF2, ArfB and ICT1 is shown in the same colors as
in (A). The structure of the C-terminal tail of ICT1 has not been determined, and is not shown. The positions of the GGQ-loop and the insertion
sequence are indicated. The sketches are the mirror pictures, so that the switch loop of RF2 or the insertion sequence of ICT1 is depicted in front, and
the E-, P- and A-site are from left to right on the ribosome. (C) Amino acid sequence alignment of various class 1 release factors. Domain 3 of E. coli
RF1, E. coli RF2, human RF1Lmt and human RF1mt were compared with E. coli ArfB (full length) and human ICT1 (amino acid residue position of 61th–
206th), using the BoxShade program. The GGQ motif, the unique insertion sequence within ArfB and ICT1, and the C-terminal extension are
underlined. The basic residues in the insertion sequence of ICT1 are highlighted in red. (D) The positions of the basic residues in the insertion
sequence of ICT1. For the ICT1[a2] mutant, K124, K126 and R129 were substituted with alanine simultaneously. The sketch is the mirror picture, so
that it is accorded with Fig. 3B.
doi:10.1371/journal.pgen.1004616.g003
ICT1 Is a Versatile Mitoribosome Rescue Factor
PLOS Genetics | www.plosgenetics.org 8 September 2014 | Volume 10 | Issue 9 | e1004616
Figure 4. The peptide-release activity of ICT1 requires the insertion sequence in the N-terminal globular domain. (A) Peptide-release
assays on 55S ribosomes without mRNA were performed as in Figure 1C, with the indicated peptide release factors. ICT1[GSQ], GGQ motif is mutated
to GSQ; ICT1[DC], C-terminal 14 amino acid residues are truncated. 55S [+] and 55S [-] indicates the assays in the presence and absence of 55S
mitoribosomes, respectively. Results represent the average of at least three independent experiments. The bars on the graph indicate SD. (B) Multi-
round translation assays with E. coli 70S ribosomes were performed with the indicated peptide release factors, using the mRNAs depicted on the left.
The utilized mRNA has no stop codon and no 39UTR at the 39-terminus. The amounts of synthesized peptide were evaluated. Red closed squares,
ICT1 Is a Versatile Mitoribosome Rescue Factor
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was further purified by Q-Sepharose column chromatography (GE
Healthcare). The protein was concentrated to 5 mg/ml, divided
into aliquots, flash-frozen, and stored at 280uC.
The E. coli expression vectors for the ICT1 mutants were
prepared by PCR, using HMICT1/pET15b. The primers for
PCR were as follows: 59-GTGGTCCTGGGTCGCAGAATGT-
GAAC-39 and 59-GTTCACATTCTGCGACCCAGGACCAC-




GAT-39 for R116A, 59-GAGCCCGTGCGGCAGGCGATAGC-
CATCACGCA-39 and 59-TGCGTGATGGCTATCGCCT-
GCCGCACGGGCTC-39 for K118A, 59-ATAGCCATCACG-
CATGCAAACAAGATCAACAG-39 and 59-CTGTTGATCT-





TTTT-39 for R129A, and 59-ATAGCCATCACGCATGCA-
AACGCGATCAACGCGTTAGGAGAGTTGATCC-39 and 59-
GGATCAACTCTCCTAACGCGTTGATCGCGTTTGCAT-
GCGTGATGGCTAT-39 for a2(124-126-129A). These mutants
were expressed and purified as described above.
In vitro 55S peptide-release assay
The heteropolymeric MFV-mRNA and the MF-stop mRNA 59-
GGGAAAAGAAAAGAAAAGAAA-AUG-UUC-GUU/UAA-
AAAAGAAAAGAAAAGAAAAUAUUGAAUU-39, containing
three codons (Met-Phe-Val or Met-Phe-stop, indicated with bold
letters in mRNA sequence) in the middle, respectively, were
prepared by run-off transcription, as reported [23]. E. coli
tRNAPhe was purchased from Sigma-Aldrich. The ac[3H]Phe-
tRNAPhe (N-acetyl-[3H]Phe-tRNAPhe) was purified by reverse-
phase HPLC on a Nucleosil 300-5 C4 column using a methanol
gradient, as described previously [24]. Human RF1Lmt and
RF1mt were expressed in E. coli and purified as described
previously [9].
All complexes were prepared in a buffer containing 20 mM
HEPES-KOH (pH 7.6), 4.5 mM Mg(OAc)2, 150 mM KOAc,
0.05 mM spermine, 2.0 mM spermidine, and 4 mM 2-mercapto-
ethanol. Ternary complexes were formed in a reaction volume of
50 ml, containing 20 pmol 55S ribosomes, 200 pmol MFV/
MFstop mRNA and 20 pmol ac[3H]Phe-tRNAPhe. The reaction
mix was incubated for 15 min at 37uC. A binding assay confirmed
that approximately 0.9 pmol of ac[3H]Phe-tRNAPhe was bound to
the ribosomes, at this point. The reactions were further incubated
(75 ml total volume) for 45 min at 25uC with 80 pmol of ICT1,
RF1Lmt or RF1mt. To stop the reaction, an equal volume of 1 N
HCl was added to the reaction. The released ac[3H]Phe was
extracted by ethyl acetate, and the amount of [3H]Phe incorpo-
rated into polypeptides was determined using a scintillation
counter. The results were evaluated relative to the 100% value
when all of the ac[3H]Phe-tRNAPhe was bound to the ribosome;
i.e., 0.9 pmol was hydrolyzed. The reactions in the absence of
mRNA were also performed as above, with the initial incubation
containing 55S ribosomes and ac[3H]Phe-tRNAPhe, except for the
second incubation for 30 min at 25uC, where 16 pmol of ICT1,
RF1Lmt or RF1mt were added.
Fig. 1B confirmed that acPhe-tRNA is programmed to P-site,
and the stop codon is properly positioned to A-site on the
ribosome, since RF1Lmt showed peptide-release activity with MF-
stop(UAA) mRNA, but not with MFV mRNA.
When the puromycin assay was performed using the ribosomal
complex prepared in Fig. 1B, approximately 9.6 pmol of acPhe
(.650%) was transferred to puromycin, while the binding assay
confirmed that only 0.9 pmol of acPhe-tRNA (100%) is bound to
ribosome in the presence of mRNA. This indicates that acPhe-
tRNA goes to P-site on the mRNA-containing ribosome as well as
on the mRNA-free ribosome. Note that acPhe-tRNA on the latter
ribosome can react with puromycin but not with RFs (RF binds to
ribosome in a stop-codon dependent manner.).
Polysome breakdown assay
Polysomes were prepared from the E. coli A19 strain, according
to the procedures described previously [25]. The standard reaction
mixtures (250 ml) contained E. coli polysomes (2.0 A260), RRFmt
(15 mg), EF-G2mt (30 mg) and peptide release factors (RF1Lmt or
RF1mt, 60 mg; ICT1, 50 mg; 10 mM puromycin). The mixtures
were incubated at 30uC for 20 min in buffer (10 mM Tris-HCl
[pH 7.5], 80 mM NH4Cl, 8.2 mM MgSO4, 1 mM DTT, and
0.5 mM GTP) and fractionated on 15%–30% (w/v) sucrose
gradients (containing 10 mM Tris-HCl [pH 7.4], 80 mM NH4Cl,
8.2 mM MgSO4, and 1 mM DTT) by centrifugation at
39,000 rpm for 2 hour, using an SW41Ti rotor (Beckman
Coulter). The gradients were recovered from top to bottom, using
a density gradient fractionator (Towa Labo, Model 152–001) while
monitoring the absorbance at 260 nm.
In vitro multi-round translation assay
DNA templates were prepared as follows. Using the plasmid
pURE1 (Post Genome Institute Co., Ltd.), DNA fragments were
amplified by PCR with the T7 promoter primer 59-GCGCGTAA-




(stall) and 39 primer 59-GAACAGGAAGAACATATGATAT-
CTCCTTCTTAAAGTT-39 (nonstop). The corresponding
mRNAs used in Fig. 2 have the following sequences. Nonstop
mRNA: 59-GGGAGACCACAACGGUUUCCCUCUAGAAA-
UAAUUUUGUUUAACUUUAAGAAGGAGAUAUCAUAU-
GUUCUUCCUGUUC-39 ; stop (UAA): 59-GGGAGACCA-
CAACGGUUUCCCUCUAGAAAUAAUUUUGUUUAACU-
UUAAGAAGGAGAUAUCAUAUGUUCUUCCUGUUCUA-
ACUGUUCUAGGGAUC-39 ; and stall (AGA): 59-GGGAGAC-
CACAACGGUUUCCCUCUAGAAAUAAUUUUGUUUAA-
CUUUAAGAAGGAGAUAUCAUAUGUUCUUCCUGUU-
CAGACUGUUCUAGGGAUC-39. (the underlined sequence
encodes the MFFLF short polypeptide). [14C]Methionine-labeled
fMet-tRNA was prepared as described previously [25].
The system was reconstituted as reported previously [11,25],
with slight modifications. Briefly, RRF was omitted from the
standard system, and EF-G2mt (0.8 mg) and RRFmt (0.2 mg) were
included as the recycling factors. E. coli RFs were omitted, and
RF1Lmt (0.5 mg), RF1mt (2 mg) and ICT1 (1.1 mg) were included.
Only phenylalanyl-tRNA synthetase and leucyl-tRNA synthetase
were included as aminoacyl-tRNA synthetase sources. Instead of
amino acid mixtures, phenylalanine and leucine were used, and
ICT1[WT]; red open squares, ICT1[GSQ]; green closed squares, ICT1[DC]; green open squares, ICT1[a2]. Results represent the average of at least three
independent experiments. The bars on the graph indicate SD. For details, see the text.
doi:10.1371/journal.pgen.1004616.g004
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[35S]methionine was omitted from the system. The other
components were the same as those described previously.
The reactions (50 mL) were started by the addition of 0.2 pmol
of PCR-amplified DNA template and 100 pmol of f[14C]Met-
tRNA. After an incubation at 37uC for the indicated time periods,
aliquots were withdrawn and added to an equal volume of 1 N
HCl, to stop the reaction. The translated polypeptides were
extracted with ethyl acetate, and the incorporation of [14C]
methionine into polypeptides was determined using a scintillation
counter.
Ribosome/ICT1 binding assay
For the SDG analysis with E. coli 70S ribosomes, reaction
mixtures (250 ml) containing 25 pmol 70S ribosomes and
250 pmol ICT1, in buffer A (10 mM Tris-HCl [pH 7.5],
80 mM NH4Cl, 8.2 mM MgSO4 and 1 mM DTT), were
incubated at 30uC for 20 min and fractionated on 15%–30%
(w/v) sucrose gradients, in the same manner as the polysome
breakdown assay. In the analysis with 55S mitoribosomes, reaction
mixtures (250 ml) containing 75 pmol 55S ribosomes and
1,250 pmol N-terminal histidine tagged ICT1 were incubated as
in the assay with 70S ribosomes and fractionated on 15%–30%
(w/v) sucrose gradients by centrifugation at 39,000 rpm for
5.5 hour, using an SW41Ti rotor (Beckman Coulter). The
fractions were analyzed by Western blotting.
For the dot-blot analysis, reaction mixtures (50 ml) containing
12.5 pmol E. coli ribosome and the indicated amount of ICT1 in
buffer A were incubated at 30uC for 20 min, loaded on a
Microcon-YM100 column (Millipore), and centrifuged at 3,0006
g at 4uC for 5 minutes. The columns were washed twice with
100 ml of buffer A. For sample recovery, the columns were
incubated with 50 ml buffer A at room temperature for 1 minute.
The samples were collected in fresh tubes from the inverted
columns by centrifugation at 10,0006g at 4uC for 5 minutes, with
rinses of 100 ml of buffer A. After the recovered samples were
brought up to a volume of 500 ml with buffer A, 50 ml aliquots
containing EDTA (f.c. 20 mM) were used as the dot-blot loading
Figure 5. The insertion sequence in the N-terminal globular domain of ICT1 does not affect ribosome binding. (A) 55S mitoribosomes
(upper panel) or E. coli 70S ribosomes (lower panel) were mixed with the indicated ICT1 proteins, and fractionated on 15%–30% (w/v) sucrose
gradients. The fractions were analyzed by Western blotting with an ICT1 antibody. For the binding to 55S mitoribosomes, His-tagged ICT1 proteins
were used. The arrows indicate the exogenous His-tagged ICT1 and endogenous ICT1. Intact His-tagged ICT1 proteins are hardly observed in the top
fractions. Proteins indicated with asterisks are proteolytic products of His-tagged ICT1, rather than ICT1 that has been chased from 55S ribosomes. (B)
The indicated amount of ICT1 proteins (open circles, ICT1[WT]; closed circles, ICT1[a2]) were incubated with E. coli 70S ribosomes (f.c. 0.25 mM). The
ribosome-bound ICT1 was recovered by a filtering technique, and quantified by Western blotting against ICT1. The amount of ribosome-bound ICT1
per 70S ribosome was plotted against the amount of ICT1. Error bars represent SD of repeated measurements. (C) 55S ribosomes were mixed with
the indicated ICT1 proteins and incubated in the presence of BS3 (f.c. 4 mM). The cross-linked products were analyzed by Western blotting with an
ICT1 antibody. Note that the cross-linked proteins with the integral ICT1 (single asterisk) are different from those with the exogenous ICT1 (two
asterisks, for example).
doi:10.1371/journal.pgen.1004616.g005
Figure 6. A model for the functions of ICT1 depicting the three scenarios involving the factor’s activity. Ribosomes might stall for many
reasons such as non-stop mRNA (left, Stalled ribosome at the end of mRNA), the defect in the membrane insertion of the nascent chain, the non-
standard stop codon (middle, Stalled ribosome in the middle of mRNA), and so on. Stalled ribosome might further lose the mRNA (right, Stalled
ribosome without mRNA). Defective initiation complex might exist (middle panel, stalled ribosome in the middle of mRNA; right, stalled ribosome
without mRNA). ICT1 is a versatile rescue factor, which can take care of all type of stalled ribosomes by exerting its peptide-release activity at
ribosomal A-site. Ribosome-free ICT1 is not yet detected in mitochondria. Accordingly, the ribosome-integrated ICT1, which is not present at A-site, is
potentially released from the ribosomes in response to the ribosomal stall, and function at the ribosomal A-site. Alternatively, It is also possible that
ICT1 is overexpressed in response to a ribosome stalling in order to produce ribosome-free ICT1, which acts on the stalled ribosome independently of
the integrated ICT1.
doi:10.1371/journal.pgen.1004616.g006
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samples. For quantification, purified recombinant ICT1 was used
as loading samples for a standard curve.
Crosslinking assay
55S ribosomes (46 pmol in 100 ml final volume) were mixed
with a 5-fold excess of ICT1, in buffer containing 20 mM Hepes-
KOH (pH 7.6), 8.2 mM MgSO4, and 80 mM NH4Cl. The
mixtures were incubated at 30uC for 20 min. The reactions were
supplemented with the amino-reactive crosslinking agent BS3
(Bis[sulfosuccinimidyl]suberate, Thermo Scientific) to a final
concentration of 4 mM, and were incubated at 25uC for
30 min. BS3 crosslinking was stopped by the addition of SDS-
PAGE loading dye. The samples were analyzed by Western
blotting.
Western blotting analysis
The polyclonal antisera for ICT1 were generated in our
laboratory, by injecting rabbits with the purified recombinant
proteins.
Supporting Information
Figure S1 RF1mt shows no peptide release activity on 55S
ribosomes, even using an excess amount. (A) The reaction mixture
(50 ml), containing 20 pmol 55S mitoribosomes, 200 pmol MFV/
MFstop mRNA and 20 pmol ac[3H]Phe-tRNAPhe, was incubated
for 15 min at 37uC. The reactions were further incubated (75 ml
total volume) for 45 min at 25uC with indicated amounts of
RF1mt or RF1Lmt.64 RF1mt/RF1Lmt corresponds to 80 pmol
proteins, which is 4-fold excess relative to the 55S mitoribosomes.
The released ac[3H]Phe was extracted by ethyl acetate, and the
amount of ac[3H]Phe was determined by scintillation counting. (B)
The reactions in the absence of mRNA were also performed as
above, the initial incubation contained the 55S ribosomes and
ac[3H]Phe-tRNAPhe.
(PDF)
Figure S2 ICT1 does not interfere with normal translation. (A)
ICT1 shows aminoacyl-tRNA hydrolase activity on 55S mitoribo-
somes in the absence of mRNA. The assay was performed as in
Fig. 1C, using [3H]Phe-tRNAPhe instead of ac[3H]Phe-tRNAPhe.
The reaction mixture (50 ml), containing 20 pmol [3H]Phe-
tRNAPhe and 20 pmol 55S mitoribosomes, was incubated for
15 min at 37uC. The reactions were further incubated (75 ml total
volume) for 30 min at 25uC with 16 pmol of RF1Lmt, RF1mt or
ICT1. The reactions were terminated with 500 ml 5% TCA and
centrifuged at 10,0006g at 4uC for 15 minutes. The supernatants
were collected and the amount of released [3H]Phe were
determined with scintillation counter. 55S [+] and 55S [2]
indicates the assays in the presence and absence of 55S
mitoribosomes, respectively. Note that TCA precipitation method
was applied to recover released [3H]Phe, due to the inefficient
extraction of [3H]Phe by ethyl acetate. Since Phe-tRNA is more
unstable than acPhe-tRNA, and is easily deacylated during
incubation, the background value of the assay (,11.0 pmol) is
higher than that of Fig. 1C (,3.0 pmol). (B) In vitro multi-round
assays of coupled transcription-translation were performed using
the ‘‘stop’’ mRNA, in the presence of the indicated peptide release
factors. For details see Figure 2A and the text. ICT1 [WT] or
ICT1 [GSQ] was competed with RF1Lmt. ICT1 does not inhibit
either the peptide release reaction by RF1Lmt or the peptide
elongation reaction.
(PDF)
Figure S3 ICT1 as well as ArfB show peptide release activity on
70S ribosomes in the absence of mRNA. The reaction mixture
(50 ml), containing 20 pmol ac[3H]Phe-tRNAPhe and 20 pmol E.
coli 70S ribosomes, was incubated for 15 min at 37uC. The
reactions were further incubated (75 ml total volume) for 45 min at
25uC with 80 pmol of RF1Lmt, RF1mt, ICT1, ICT1 mutants or
ArfB. The released ac[3H]Phe was extracted by ethyl acetate, and
the amount of ac[3H]Phe was determined with a scintillation
counter.
(PDF)
Figure S4 Single alanine substitution mutations in the insertion
sequence of ICT1 have minimal effects on the peptide release
activity of ICT1. In vitro multi-round translation assays were
performed with the indicated ICT1 mutants, using the ‘‘stall’’
mRNA. Details about the mutants in Figure 3D; the procedure is
illustrated in Figure 2A.
(PDF)
Figure S5 Interaction of the insertion sequence of ICT1 with
23S rRNA. Left, overview of the structure of ICT1 on the 70S
ribosome [5]. ICT1, red; tRNAfMet, blue; 50S, green; 30S, light
blue. The insertion sequence in the N-terminal domain of ICT1 is
colored orange. Right, close-up view of the interaction between
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